Clinical trial
The Double-Blind, Randomized, Multi-Center, and Active Controlled Trial for Efficacy and Safety of Cilostazol in Acute Ischemic Stroke
NCT00272454 is registered in ClinicalTrials.gov with Korea Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Double-Blind, Randomized, Multi-Center, and Active Controlled Trial for Efficacy and Safety of Cilostazol in Acute Ischemic Stroke
- Lead sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- September 30, 2008
- Enrollment
- 468 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.